Radiopharm Theranostics Limited American Depositary Shares

RADXNASDAQUSD
2.65 USD
0.13 (4.68%)AT CLOSE (11:59 AM EDT)
2.77
0.12 (4.34%)
POST MARKET (AS OF 07:53 PM EDT)
Post Market
AS OF 07:53 PM EDT
2.77
0.12 (4.34%)
🔴Market: CLOSED

RADX is currently priced at $2.63. The technical outlook is "Strong Sell" based on moving average alignment, RSI, and MACD signals. Key drivers include a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment.

Technical & fundamental data as of Aug 13, 2026.

Open?$2.80
High?$2.81
Low?$2.63
Prev. Close?$2.78
Volume?51.0K
Avg. Volume?N/A
VWAP?$2.69
Bid / Ask
Bid?$2.27 × 100
Ask?$3.15 × 100
Spread?$0.88
Midpoint?$2.71
Valuation & Ratios
Market Cap?21.9M
Shares Out?13.1M
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
News
Profile
Radiopharm Theranostics Ltd is an Australian-based clinical-stage radiotherapeutics company targeting cancer. The company has a pipeline of approximately four licensed platform technologies, with diagnostic and therapeutic applications at both the pre-clinical and clinical stages of development. The company is engaged in research, development, and commercialization of health technologies.
Employees
14
Market Cap
21.9M
Industry
N/A
Listed
2024-11-27
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bearish(-3/3)
Medium-Term (Wave)? Bearish(-2/3)
Short-Term (Ripple)? Bearish(-1/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental Outlook
Loading...
Short InterestLow
Short Interest?74.1K
Days to Cover?1.0
Avg Daily Volume194.7K
Settlement Date2026-07-31